re: Ann: JP Morgan Healthcare Conference Pres... This investor preview article gives a sense of how important the conference is, as the 'oldest, largest and most important healthcare conference' even if PRR is currently still a tiddler.
http://www.thestreet.com/story/10962460/1/biotechs-2011-kickoff-party-investor-preview.html
In another link I was vaguely interested to note that PRR is one of the 99 cancer investigators listed by name (in table 183) of 'Commercialising Cancer Vaccines: A decision Support Tool for Optimising the Pipeline.' (Don't bother Googling it, - costs $2730 and is for optimising the commercialisation of cancer vaccines, not optimising bio-investment decisions.)
re: Ann: JP Morgan Healthcare Conference Pres... This investor...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.5¢ |
Change
0.005(1.28%) |
Mkt cap ! $573.7M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 40.0¢ | 38.5¢ | $1.022M | 2.599M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 17394 | 39.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 60247 | 1 |
View Market Depth
| Last trade - 16.10pm 05/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |